{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T08:50:34Z","timestamp":1783759834220,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol Exp"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Dual-energy computed tomography (DECT) detects monosodium urate (MSU) deposits in joints. However, the correlation between coronary atherosclerosis phenotypes and MSU-positive lesions in the cardiovascular system remains unclear. We investigated the correlation between coronary MSU-positive plaques on unenhanced DECT with the coronary atherosclerosis profile at coronary CT angiography.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>One hundred fifty rheumatologic patients were prospectively enrolled. Sixty of them underwent unenhanced DECT and 128-row DECT coronary angiography. Analysis included CAD-RADS stenosis severity, high-risk plaque (HRP) phenotypes, and coronary artery calcium (CAC) score.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Of 60 patients, with a mean age of 63.7 years, including 7 females (11.7%), 37 had gout (61.7%), 9 had hyperuricemia (15%), and 14 had other rheumatologic diseases (23.3%). At DECT, 11 (18.3%) had coronary MSU-positive lesions totaling 24 lesions (left anterior descending, 12; right coronary artery, 10; circumflex, 1; left main, 1). HRP phenotypes were identified in 14 of 60 patients (23.3%). The prevalence of HRP was higher in MSU-positive than MSU-negative patients (63.3% <jats:italic>versus<\/jats:italic> 14.2%; <jats:italic>p<\/jats:italic>\u2009=\u20090.003; odds ratio 9.91; 95% confidence interval [CI]: 2.30\u201348.41). CAD-RADS and CAC scores correlated with the number of MSU-positive lesions (\u03c1\u2009=\u20090.412; 95% CI: 0.167\u20130.609; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and \u03c1\u2009=\u20090.412; 95% CI: 0.169\u20130.609; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). None of the major cardiovascular risk factors (smoking, hypertension, dyslipidemia, or diabetes) was associated with MSU-positive lesions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>We found an association between coronary MSU-positive lesions and HRP-phenotypes, as well as a correlation with stenosis severity and calcium burden. MSU-positive lesions may serve as an unenhanced DECT-derived biomarker of increased cardiovascular risk.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Relevance statement<\/jats:title>\n            <jats:p>The detection of coronary MSU-positive lesions by DECT could indicate an increased likelihood of HRP phenotypes. These findings suggest their potential as imaging biomarkers for cardiovascular risk, using unenhanced spectral DECT scans or photon-counting CT.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Key Points<\/jats:title>\n            <jats:p>\n              <jats:list list-type=\"bullet\">\n                <jats:list-item>\n                  <jats:p>Identifying gout patients with increased cardiovascular risk remains challenging.<\/jats:p>\n                <\/jats:list-item>\n                <jats:list-item>\n                  <jats:p>Coronary MSU-positive lesions detected on unenhanced DECT may be associated with HRP features on coronary computed tomography angiography.<\/jats:p>\n                <\/jats:list-item>\n                <jats:list-item>\n                  <jats:p>MSU-positive lesions could serve as biomarkers for cardiovascular risk in gout patients.<\/jats:p>\n                <\/jats:list-item>\n              <\/jats:list>\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical Abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1186\/s41747-025-00611-z","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T17:16:43Z","timestamp":1754932603000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Association between coronary monosodium urate deposits at DECT and high-risk coronary plaque phenotypes and other features in gout patients"],"prefix":"10.1186","volume":"9","author":[{"given":"Pietro G.","family":"Lacaita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea S.","family":"Klauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Held","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Haschka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerlig","family":"Widmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6755-4399","authenticated-orcid":false,"given":"Gudrun M.","family":"Feuchtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"key":"611_CR1","doi-asserted-by":"publisher","first-page":"649505","DOI":"10.3389\/fmed.2021.649505","volume":"8","author":"MI Ahmad","year":"2021","unstructured":"Ahmad MI, Masood S, Furlanetto DM, Nicolaou S (2021) Urate crystals: beyond joints. Front Med 8:649505. https:\/\/doi.org\/10.3389\/fmed.2021.649505","journal-title":"Front Med"},{"key":"611_CR2","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1093\/rheumatology\/keae240","volume":"64","author":"J Held","year":"2025","unstructured":"Held J, Schwabl C, Haschka D et al (2025) Major cardiovascular events in patients with cardiovascular monosodium urate deposits in atherosclerotic plaques. Rheumatology 64:1443\u20131447. https:\/\/doi.org\/10.1093\/rheumatology\/keae240","journal-title":"Rheumatology"},{"key":"611_CR3","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1001\/jama.2016.3517","volume":"315","author":"SY Lim","year":"2016","unstructured":"Lim SY, Lu N, Oza A et al (2016) Trends in gout and rheumatoid arthritis hospitalizations in the United States, 1993-2011. JAMA 315:2345\u20132347. https:\/\/doi.org\/10.1001\/jama.2016.3517","journal-title":"JAMA"},{"key":"611_CR4","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/qjmed\/hcw083","volume":"109","author":"R Angalla","year":"2016","unstructured":"Angalla R, Mounir A, Driouich S et al (2016) Chronic tophaceous gout. QJM 109:681\u2013682. https:\/\/doi.org\/10.1093\/qjmed\/hcw083","journal-title":"QJM"},{"key":"611_CR5","doi-asserted-by":"publisher","first-page":"e507","DOI":"10.1016\/S2665-9913(24)00117-6","volume":"6","author":"GBD 2021 Gout Collaborators","year":"2024","unstructured":"GBD 2021 Gout Collaborators (2024) Global, regional, and national burden of gout, 1990-2020, and projections to 2050: a systematic analysis of the global burden of disease study 2021. Lancet Rheumatol 6:e507\u2013e517. https:\/\/doi.org\/10.1016\/S2665-9913(24)00117-6","journal-title":"Lancet Rheumatol"},{"key":"611_CR6","doi-asserted-by":"publisher","first-page":"e23582","DOI":"10.7759\/cureus.23582","volume":"14","author":"M Freilich","year":"2022","unstructured":"Freilich M, Arredondo A, Zonnoor SL, McFarlane IM (2022) Elevated serum uric acid and cardiovascular disease: a review and potential therapeutic interventions. Cureus 14:e23582. https:\/\/doi.org\/10.7759\/cureus.23582","journal-title":"Cureus"},{"key":"611_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jjcc.2020.12.013","volume":"78","author":"Y Saito","year":"2021","unstructured":"Saito Y, Tanaka A, Node K, Kobayashi Y (2021) Uric acid and cardiovascular disease: a clinical review. J Cardiol 78:51\u201357. https:\/\/doi.org\/10.1016\/j.jjcc.2020.12.013","journal-title":"J Cardiol"},{"key":"611_CR8","doi-asserted-by":"publisher","first-page":"e16097","DOI":"10.1016\/j.heliyon.2023.e16097","volume":"9","author":"K Li","year":"2023","unstructured":"Li K, Li K, Yao Q et al (2023) The potential relationship of coronary artery disease and hyperuricemia: a cardiometabolic risk factor. Heliyon 9:e16097. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e16097","journal-title":"Heliyon"},{"key":"611_CR9","doi-asserted-by":"publisher","first-page":"e17161","DOI":"10.7759\/cureus.17161","volume":"13","author":"J Padda","year":"2021","unstructured":"Padda J, Khalid K, Almanie AH et al (2021) Hyperuricemia in patients with coronary artery disease and its association with disease severity. Cureus 13:e17161. https:\/\/doi.org\/10.7759\/cureus.17161","journal-title":"Cureus"},{"key":"611_CR10","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.jcmg.2019.10.019","volume":"13","author":"JL Christensen","year":"2020","unstructured":"Christensen JL, Yu W, Tan S et al (2020) Gout is associated with increased coronary artery calcification and adverse cardiovascular outcomes. JACC Cardiovasc Imaging 13:884\u2013886. https:\/\/doi.org\/10.1016\/j.jcmg.2019.10.019","journal-title":"JACC Cardiovasc Imaging"},{"key":"611_CR11","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1001\/jamacardio.2019.3201","volume":"4","author":"AS Klauser","year":"2019","unstructured":"Klauser AS, Halpern EJ, Strobl S et al (2019) Dual-energy computed tomography detection of cardiovascular monosodium urate deposits in patients with gout. JAMA Cardiol 4:1019\u20131028. https:\/\/doi.org\/10.1001\/jamacardio.2019.3201","journal-title":"JAMA Cardiol"},{"key":"611_CR12","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.1007\/s00330-016-4237-2","volume":"26","author":"T Finkenstaedt","year":"2016","unstructured":"Finkenstaedt T, Manoliou A, Toniolo M et al (2016) Gouty arthritis: the diagnostic and therapeutic impact of dual-energy CT. Eur Radiol 26:3989\u20133999. https:\/\/doi.org\/10.1007\/s00330-016-4237-2","journal-title":"Eur Radiol"},{"key":"611_CR13","doi-asserted-by":"publisher","first-page":"e000593","DOI":"10.1136\/rmdopen-2017-000593","volume":"4","author":"P Wang","year":"2018","unstructured":"Wang P, Smith SE, Garg R et al (2018) Identification of monosodium urate crystal deposits in patients with asymptomatic hyperuricemia using dual-energy CT. RMD Open 4:e000593. https:\/\/doi.org\/10.1136\/rmdopen-2017-000593","journal-title":"RMD Open"},{"key":"611_CR14","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1007\/s11547-024-01827-6","volume":"129","author":"D Albano","year":"2024","unstructured":"Albano D, Di Luca F, D\u2019Angelo T et al (2024) Dual-energy CT in musculoskeletal imaging: technical considerations and clinical applications. Radiol Med 129:1038\u20131047. https:\/\/doi.org\/10.1007\/s11547-024-01827-6","journal-title":"Radiol Med"},{"key":"611_CR15","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1097\/RCT.0000000000001222","volume":"45","author":"GM Feuchtner","year":"2021","unstructured":"Feuchtner GM, Plank F, Beyer C et al (2021) Monosodium urate crystal deposition in coronary artery plaque by 128-slice dual-energy computed tomography: An ex vivo phantom and in vivo Study. J Comput Assist Tomogr 45:856\u2013862. https:\/\/doi.org\/10.1097\/RCT.0000000000001222","journal-title":"J Comput Assist Tomogr"},{"key":"611_CR16","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1097\/HJH.0000000000003807","volume":"42","author":"E Fiori","year":"2024","unstructured":"Fiori E, De Fazio L, Pidone C et al (2024) Asymptomatic hyperuricemia: to treat or not a threat? A clinical and evidence-based approach to the management of hyperuricemia in the context of cardiovascular diseases. J Hypertens 42:1665\u20131680. https:\/\/doi.org\/10.1097\/HJH.0000000000003807","journal-title":"J Hypertens"},{"key":"611_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1136\/annrheumdis-2019-215315","volume":"79","author":"P Richette","year":"2020","unstructured":"Richette P, Doherty M, Pascual E et al (2020) 2018 updated european league against rheumatism evidence-based recommendations for the diagnosis of gout. Ann Rheum Dis 79:31\u201338. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215315","journal-title":"Ann Rheum Dis"},{"key":"611_CR18","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.jacc.2007.10.034","volume":"51","author":"KE Kip","year":"2008","unstructured":"Kip KE, Hollabaugh K, Marroquin OC, Williams DO (2008) The problem with composite end points in cardiovascular studies: the story of major adverse cardiac events and percutaneous coronary intervention. J Am Coll Cardiol 51:701\u2013707. https:\/\/doi.org\/10.1016\/j.jacc.2007.10.034","journal-title":"J Am Coll Cardiol"},{"key":"611_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/jmrs.223","volume":"64","author":"H Chou","year":"2017","unstructured":"Chou H, Chin TY, Peh WCG (2017) Dual-energy CT in gout\u2014a review of current concepts and applications. J Med Radiat Sci 64:41\u201351. https:\/\/doi.org\/10.1002\/jmrs.223","journal-title":"J Med Radiat Sci"},{"key":"611_CR20","doi-asserted-by":"publisher","first-page":"184","DOI":"10.4329\/wjr.v12.i8.184","volume":"12","author":"SH Barazani","year":"2020","unstructured":"Barazani SH, Chi W-W, Pyzik R et al (2020) Quantification of uric acid in vasculature of patients with gout using dual-energy computed tomography. World J Radiol 12:184\u2013194. https:\/\/doi.org\/10.4329\/wjr.v12.i8.184","journal-title":"World J Radiol"},{"key":"611_CR21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejrad.2016.12.012","volume":"87","author":"M K\u00e1rolyi","year":"2017","unstructured":"K\u00e1rolyi M, Szilveszter B, Kolossv\u00e1ry M et al (2017) Iterative model reconstruction reduces calcified plaque volume in coronary CT angiography. Eur J Radiol 87:83\u201389. https:\/\/doi.org\/10.1016\/j.ejrad.2016.12.012","journal-title":"Eur J Radiol"},{"key":"611_CR22","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1007\/s10067-018-3980-y","volume":"37","author":"M Gamala","year":"2018","unstructured":"Gamala M, Linn-Rasker SP, Nix M et al (2018) Gouty arthritis: decision-making following dual-energy CT scan in clinical practice, a retrospective analysis. Clin Rheumatol 37:1879\u20131884. https:\/\/doi.org\/10.1007\/s10067-018-3980-y","journal-title":"Clin Rheumatol"},{"key":"611_CR23","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-t","volume":"15","author":"AS Agatston","year":"1990","unstructured":"Agatston AS, Janowitz WR, Hildner FJ et al (1990) Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15:827\u2013832. https:\/\/doi.org\/10.1016\/0735-1097(90)90282-t","journal-title":"J Am Coll Cardiol"},{"key":"611_CR24","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.jcct.2022.07.002","volume":"16","author":"RC Cury","year":"2022","unstructured":"Cury RC, Leipsic J, Abbara S et al (2022) CAD-RADSTM 2.0\u20142022 coronary artery disease-reporting and data system. J Cardiovasc Comput Tomogr 16:536\u2013557. https:\/\/doi.org\/10.1016\/j.jcct.2022.07.002","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"611_CR25","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/ehjci\/jet132","volume":"15","author":"R Nakazato","year":"2014","unstructured":"Nakazato R, Arsanjani R, Achenbach S et al (2014) Age-related risk of major adverse cardiac event risk and coronary artery disease extent and severity by coronary CT angiography: results from 15 187 patients from the international multisite CONFIRM study. Eur Heart J Cardiovasc Imaging 15:586\u2013594. https:\/\/doi.org\/10.1093\/ehjci\/jet132","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"611_CR26","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1161\/CIRCULATIONAHA.119.044720","volume":"141","author":"MC Williams","year":"2020","unstructured":"Williams MC, Kwiecinski J, Doris M et al (2020) Low-Attenuation noncalcified plaque on coronary computed tomography angiography predicts myocardial infarction: results from the multicenter SCOT-HEART trial (Scottish Computed Tomography of the HEART). Circulation 141:1452\u20131462. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.044720","journal-title":"Circulation"},{"key":"611_CR27","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jcmg.2012.03.019","volume":"5","author":"P Maurovich-Horvat","year":"2012","unstructured":"Maurovich-Horvat P, Schlett CL, Alkadhi H et al (2012) The napkin-ring sign indicates advanced atherosclerotic lesions in coronary CT angiography. JACC Cardiovasc Imaging 5:1243\u20131252. https:\/\/doi.org\/10.1016\/j.jcmg.2012.03.019","journal-title":"JACC Cardiovasc Imaging"},{"key":"611_CR28","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1161\/ATVBAHA.124.321504","volume":"44","author":"C Onnis","year":"2024","unstructured":"Onnis C, Virmani R, Madra A et al (2024) Whys and wherefores of coronary arterial positive remodeling. Arterioscler Thromb Vasc Biol 44:2416\u20132427. https:\/\/doi.org\/10.1161\/ATVBAHA.124.321504","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"611_CR29","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41392-024-01916-y","volume":"9","author":"L Du","year":"2024","unstructured":"Du L, Zong Y, Li H et al (2024) Hyperuricemia and its related diseases: mechanisms and advances in therapy. Signal Transduct Target Ther 9:212. https:\/\/doi.org\/10.1038\/s41392-024-01916-y","journal-title":"Signal Transduct Target Ther"},{"key":"611_CR30","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1002\/acr.25312","volume":"76","author":"C Yokose","year":"2024","unstructured":"Yokose C, Eide SE, Huber FA et al (2024) Frequently encountered artifacts in the application of dual-energy computed tomography to cardiovascular imaging for urate crystals in gout: a matched-control study. Arthritis Care Res 76:953\u2013963. https:\/\/doi.org\/10.1002\/acr.25312","journal-title":"Arthritis Care Res"},{"key":"611_CR31","doi-asserted-by":"publisher","unstructured":"Lacaita PG, Luger A, Troger F et al (2024) Photon-counting detector computed tomography (PCD-CT): a new era for cardiovascular imaging? Current status and future outlooks. J Cardiovasc Dev Dis. https:\/\/doi.org\/10.3390\/jcdd11040127","DOI":"10.3390\/jcdd11040127"}],"container-title":["European Radiology Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41747-025-00611-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41747-025-00611-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41747-025-00611-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T17:16:44Z","timestamp":1754932604000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurradiolexp.springeropen.com\/articles\/10.1186\/s41747-025-00611-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["611"],"URL":"https:\/\/doi.org\/10.1186\/s41747-025-00611-z","relation":{},"ISSN":["2509-9280"],"issn-type":[{"value":"2509-9280","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"assertion":[{"value":"27 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This prospective study was conducted in accordance with the Declaration of Helsinki. Approval of the Institutional Review Board (IRB) (Ethics Commission of the Medical Faculty, Medical University of Innsbruck, Austria; reference no. 1331\/2019.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Participants gave their written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No financial disclosures.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"73"}}